As healthcare reform advances, experts say, dermatologists face mounting pressure to prove their mettle to insurance exchanges and accountable care organizations (ACOs).
As healthcare reform advances, experts say, dermatologists face mounting pressure to prove their mettle to insurance exchanges and accountable care organizations (ACOs).
Jack Resneck Jr., M.D., defines a healthcare exchange as a tool, usually a website, that individuals or small businesses (which the Affordable Care Act/ACA defines as having fewer than 50 employees) use to choose a healthcare plan. Dr. Resneck is associate professor and vice chairman of dermatology, Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, School of Medicine, and a member of the American Academy of Dermatology (AAD) board of directors.
Although only some dermatologists currently participate in healthcare exchange plans, he says, “What’s happening in the exchange plans will be spreading to other commercial insurance products, not at the government’s behest, but due to insurers’ desires.
Read the full story here: http://bit.ly/WKioj6
Source: Dermatology Times
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
NSAIDs vs bDMARDs: Sex Disparities in Treatment Initiation for Axial Spondyloarthritis
April 12th 2024New research examining treatment initiation patterns among patients with axial spondyloarthritis revealed significant sex-based disparities, shedding light on the process from diagnosis to therapeutic intervention.
Read More